215 related articles for article (PubMed ID: 17046051)
1. Atherosclerosis and the protective role played by different proteins in apolipoprotein E-deficient mice.
Fabrizio Rodella L; Bonomini F; Rezzani R; Tengattini S; Hayek T; Aviram M; Keidar S; Coleman R; Bianchi R
Acta Histochem; 2007; 109(1):45-51. PubMed ID: 17046051
[TBL] [Abstract][Full Text] [Related]
2. Endogenous angiotensin II enhances atherogenesis in apoprotein E-deficient mice with renovascular hypertension through activation of vascular smooth muscle cells.
Heo HJ; Yun MR; Jung KH; Lee JY; Park JY; Lee SJ; Bae SS; Lee WS; Kim CD
Life Sci; 2007 Feb; 80(11):1057-63. PubMed ID: 17204292
[TBL] [Abstract][Full Text] [Related]
3. A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice.
Coleman R; Hayek T; Keidar S; Aviram M
Acta Histochem; 2006; 108(6):415-24. PubMed ID: 17007910
[TBL] [Abstract][Full Text] [Related]
4. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
Desai A; Zhao Y; Warren JS
Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
[TBL] [Abstract][Full Text] [Related]
5. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.
Miyoshi T; Li Y; Shih DM; Wang X; Laubach VE; Matsumoto AH; Helm GA; Lusis AJ; Shi W
Life Sci; 2006 Jul; 79(6):525-31. PubMed ID: 16516241
[TBL] [Abstract][Full Text] [Related]
7. Micro ATR-FTIR spectroscopic imaging of atherosclerosis: an investigation of the contribution of inducible nitric oxide synthase to lesion composition in ApoE-null mice.
Palombo F; Shen H; Benguigui LE; Kazarian SG; Upmacis RK
Analyst; 2009 Jun; 134(6):1107-18. PubMed ID: 19475136
[TBL] [Abstract][Full Text] [Related]
8. Swimming reduces the severity of atherosclerosis in apolipoprotein E deficient mice by antioxidant effects.
Okabe TA; Shimada K; Hattori M; Murayama T; Yokode M; Kita T; Kishimoto C
Cardiovasc Res; 2007 Jun; 74(3):537-45. PubMed ID: 17374527
[TBL] [Abstract][Full Text] [Related]
9. Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life.
Alkemade FE; Gittenberger-de Groot AC; Schiel AE; VanMunsteren JC; Hogers B; van Vliet LS; Poelmann RE; Havekes LM; Willems van Dijk K; DeRuiter MC
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2228-35. PubMed ID: 17656671
[TBL] [Abstract][Full Text] [Related]
10. Remodelling of the zero-stress state and residual strains in apoE-deficient mouse aorta.
Gregersen H; Zhao J; Lu X; Zhou J; Falk E
Biorheology; 2007; 44(2):75-89. PubMed ID: 17538200
[TBL] [Abstract][Full Text] [Related]
11. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
[TBL] [Abstract][Full Text] [Related]
12. Morphological and functional alterations of the cochlea in apolipoprotein E gene deficient mice.
Guo Y; Zhang C; Du X; Nair U; Yoo TJ
Hear Res; 2005 Oct; 208(1-2):54-67. PubMed ID: 16051453
[TBL] [Abstract][Full Text] [Related]
13. In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed Evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E-deficient mice.
Yasuda S; Ikuta K; Uwatoku T; Oi K; Abe K; Hyodo F; Yoshimitsu K; Sugimura K; Utsumi H; Katayama Y; Shimokawa H
J Vasc Res; 2008; 45(2):123-8. PubMed ID: 17940339
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E and its role in aging and survival.
Bonomini F; Filippini F; Hayek T; Aviram M; Keidar S; Rodella LF; Coleman R; Rezzani R
Exp Gerontol; 2010 Feb; 45(2):149-57. PubMed ID: 19941948
[TBL] [Abstract][Full Text] [Related]
15. Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(-/-) mice.
Matsui R; Xu S; Maitland KA; Mastroianni R; Leopold JA; Handy DE; Loscalzo J; Cohen RA
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):910-6. PubMed ID: 16439706
[TBL] [Abstract][Full Text] [Related]
16. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
Luttun A; Lutgens E; Manderveld A; Maris K; Collen D; Carmeliet P; Moons L
Circulation; 2004 Mar; 109(11):1408-14. PubMed ID: 14993123
[TBL] [Abstract][Full Text] [Related]
17. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice.
Jacob S; Laury-Kleintop L; Lanza-Jacoby S
J Surg Res; 2008 May; 146(1):135-42. PubMed ID: 17950326
[TBL] [Abstract][Full Text] [Related]
18. Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoprotein-receptor/apolipoprotein B48-deficient mice.
Leppänen P; Koota S; Kholová I; Koponen J; Fieber C; Eriksson U; Alitalo K; Ylä-Herttuala S
Circulation; 2005 Aug; 112(9):1347-52. PubMed ID: 16129816
[TBL] [Abstract][Full Text] [Related]
19. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
Harrington SC; Simari RD; Conover CA
Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
[TBL] [Abstract][Full Text] [Related]
20. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
